Bioxcel Therapeutics(DE:BX20)
€0.070.00 (0.00%)
DE:BX20
Bioxcel Therapeutics earnings date
€0.07
At close:0.00 (0.00%)
Bioxcel Therapeutics (BX20) Q2 2023 Earnings Report
10 Followers
DE:BX20 Q2 2023 EPS Results
- Actual EPS
- -EUR 26.69
- Consensus EPS
- -EUR 25.43
- Beat/Miss
- Missed by -EUR 1.26
- One Year Ago EPS
- -EUR 19.69
DE:BX20 Q2 2023 Revenue Results
- Actual Revenue
- EUR 416.59K
- Expected Revenue
- EUR 413.86K
- Beat/Miss
- Beat by +EUR 2,734.741
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/14/2023
- Time
- Before Open
- Conference Call
- Monday, August 14, 2023
DE:BX20 Upcoming Earnings
Bioxcel Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:BX20 Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BX20 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | ―- | -0.53 | ― | ― |
| Nov 18, 2026 | 2026 (Q3) | -0.92- | -1.99 | ― | |
| Aug 11, 2026 | 2026 (Q2) | -0.40-0.44 | -2.23 | 80.16% (+1.79) | |
| May 15, 2026 | 2026 (Q1) | -0.48-0.49 | -1.37 | 64.00% (+0.88) | |
| Mar 27, 2026 | 2025 (Q4) | -0.58-0.53 | -3.25 | 83.75% (+2.73) | |
| Nov 12, 2025 | 2025 (Q3) | -1.22-1.99 | -4.67 | 57.42% (+2.68) | |
| Aug 12, 2025 | 2025 (Q2) | -1.69-2.23 | -3.06 | 27.08% (+0.83) | |
| May 12, 2025 | 2025 (Q1) | -2.48-1.37 | -12.69 | 89.22% (+11.32) | |
| Mar 27, 2025 | 2024 (Q4) | -5.51-3.25 | -11.08 | 70.64% (+7.83) | |
| Nov 14, 2024 | 2024 (Q3) | -7.37-4.67 | -25.09 | 81.40% (+20.42) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

